Drug Markets/Nalbuphine Hydrochloride

Nalbuphine Hydrochloride

3 NDCs across 2 manufacturers|3 Generic,0 Brand

Nalbuphine Hydrochloride is used to treat postoperative pain, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved Jul 2, 1986.

Nalbuphine Hydrochloride is available as 3 NDCs from 2 manufacturers (3 generic, 0 brand), with NADAC prices from $4.32 to $4.32 per ML. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

3G / 0B

Manufacturers

2

competing in market

Price Spread

$4.32 – $4.32

per ML

7d Activity

3 flat

avg +0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

2 manufacturers producing NALBUPHINE HYDROCHLORIDE

Drug Portfolio

3 NDCs total, 3 shown

Drug ↕Price 7d Change ↕
NALBUPHINE 10 MG/ML AMPUL
$4.3216
per ML
—
NALBUPHINE 10 MG/ML AMPUL
$4.3216
per ML
—
NALBUPHINE 10 MG/ML AMPUL
$4.3216
per ML
—

Frequently Asked Questions

What is Nalbuphine Hydrochloride used to treat?

Nalbuphine Hydrochloride is used to treat postoperative pain, per the National Library of Medicine's MED-RT classification.

When did Nalbuphine Hydrochloride become available as a generic?

FDA approved the first generic Nalbuphine Hydrochloride (ANDA) on Jul 2, 1986.

How many Nalbuphine Hydrochloride products are on the market?

The Nalbuphine Hydrochloride drug market contains 3 NDCs from 2 manufacturers — 3 generic and 0 brand products.

What is the price range for Nalbuphine Hydrochloride?

NADAC reference prices for Nalbuphine Hydrochloride range from $4.3216 to $4.3216 per ML.

Which manufacturers make Nalbuphine Hydrochloride?

2 manufacturers list Nalbuphine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (2), Somerset Therapeutics, LLC (1).